Tag: astrazeneca
Facebook changes misinfo rules to allow posts claiming COVID-19 is man-made
Facebook made a few noteworthy changes to its misinformation policies this week, including the news that the company will now allow claims that COVID was created by humans — a theory that contradicts the previously prevailing assumption that humans picked up the virus naturally from animals. “In light of ongoing…
Read More
FDA authorizes Moderna’s COVID-19 vaccine for emergency use
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine, as expected after an independent panel commissioned by the administration recommended its approval earlier this week. This is the second vaccine now authorized for use in the U.S. under EUA, after the…
Read More
AWS expands on SageMaker capabilities with end-to-end features for machine learning
Nearly three years after it was first launched, Amazon Web Services’ SageMaker platform has gotten a significant upgrade in the form of new features making it easier for developers to automate and scale each step of the process to build new automation and machine learning capabilities, the company said. As…
Read More
Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today
Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and determined that it was 94.1% effective in preventing people from contracting COVID-19 across 196 confirmed cases from among 30,000 participants in the study. Moderna also found that it was 100%…
Read More
AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy
AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the more effective dosage in the existing Phase 3 clinical trial was actually administered by accident. AstraZeneca and its partner the University of Oxford…
Read More
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to dosing, including one where two full strength does were applied, which was 62% effective,…
Read More